Last reviewed · How we verify
NCT04679701
Using Direct Molding Socket Technology for Trans-tibial Prosthesis in Developing Regions
trial testing Amparo Confidence Socket in Transtibial Amputees in 27 participants. Completed in 30 November 2020.
12 March 2020
Quick facts
| Lead sponsor | Amparo GmbH |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 27 |
| Start date | 8 July 2019 |
| Primary completion | 12 March 2020 |
| Estimated completion | 30 November 2020 |
| Sites | 2 locations across Kenya |
Drugs / interventions tested
- Amparo Confidence Socket
Conditions studied
- Transtibial Amputees — all drugs for Transtibial Amputees →
Sponsor
Amparo GmbH
Who can join
18 and older, any sex, with Transtibial Amputees. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study aims to understand how well CPOs and amputees can adapt to using the Amparo socket technology. CPOs at the APDK and The Cure will be trained to use the Amparo socket technology then use it with their consenting patients for a span of 7 months. Survey information will be collected along the way to assess how well the product is adapted by CPOs and patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04679701
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Transtibial Amputees
Currently open trials in the same condition.
- NCT07329738 — Single-Subject Research Design on 3D-Printed Prosthetic Sockets · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04679701 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Amparo GmbH
- Last refreshed: 22 December 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04679701.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing